Northwest & Ethical Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,782
Closed -$916K 515
2025
Q3
$916K Buy
13,782
+1,570
+13% +$124K 0.02% 344
2025
Q2
$1.05M Buy
12,212
+2,400
+24% +$188K 0.03% 324
2025
Q1
$669K Buy
+9,812
New +$801K 0.02% 364
2024
Q3
Sell
-2,425
Closed -$199K 522
2024
Q2
$275K Buy
2,425
+225
+10% +$28.4K 0.01% 375
2024
Q1
$305K Buy
+2,200
New +$277K 0.01% 376

Other funds holding DXCM

Northwest & Ethical Investments's DXCM Position: Q4 2025 in Review

Northwest & Ethical Investments sold out of DexCom (DXCM) in Q4 2025, closing a stake of 13,782 shares — an estimated $916K sold.

Northwest & Ethical Investments first reported a position in DXCM in Q1 2024 and held it in 5 quarters. The position peaked at $1.05M in Q2 2025. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Northwest & Ethical Investments reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Northwest & Ethical Investments sold 13,782 DexCom shares in Q4 2025, an estimated $916K.
  • Northwest & Ethical Investments first reported a position in DexCom in Q1 2024 and held it in 5 quarters.
  • Northwest & Ethical Investments's DexCom position peaked at $1.05M in Q2 2025.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Northwest & Ethical Investments's 13F filing for Q4 2025, filed 12 Feb 2026.